Nlrp3 inflammasome inhibitor and use thereof
AssigneeTransthera Sciences (Nanjing), Inc.
InventorsLin Li, Frank Wu
Life of this patent
Estimating the term…
Loading patent…
AssigneeTransthera Sciences (Nanjing), Inc.
InventorsLin Li, Frank Wu
Estimating the term…
The present invention belongs to the technical field of medicine, relates to an NLRP3 inflammasome inhibitor and a use thereof, and specifically relates to a compound represented by a general formula (A′) or a pharmaceutically acceptable salt, stereoisomer and deuterated product thereof, the definition of each group being as defined in the description. Studies have shown that the compound represented by general formula (A′) or the pharmaceutically acceptable salt, stereoisomer and deuterated product thereof have high biological activity against an NLRP3 inflammasome, and have important clinical development value for the treatment of NLRP3-related diseases.
A compound represented by general formula (A′) or a pharmaceutically acceptable salt, a stereoisomer or a deuteride thereof:
(canceled)
Dependencies are inferred from the claim text.